Genfit advances nangibotide Phase 2 clinical investigation in Aclf
Genfit SA said it is advancing nangibotide in a Phase 2 clinical investigation in Aclf.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.